| 產(chǎn)品名稱： |
泰諾福韋,98% |
| 中文別名： |
泰諾福韋;(R)-9-(2-磷酸甲氧基丙基)-腺嘌呤;泰諾福韋中間體PMPA;替諾福韋;替諾福韋(泰諾福韋);泰諾福韋(PMPA);替諾福韋水合物;(R)-9-(2-磷酸甲氧基丙基)-腺嘌;(R)-9-(2-磷酸甲氧基丙基)-腺嘌呤 (PMPA);(R)-9-(2-羥基丙基)腺嘌呤;R-9-(2-磷酸氧甲基)丙基腺嘌呤;TDF雜質(zhì)P;富馬酸替諾福韋酯（TDF）;過氧化氫酶;甲磺酸(2-二環(huán)己基膦基-2'',6''-二異丙氧基-1,1''-聯(lián)苯基)(2-氨基-1,1''-聯(lián)苯-2-基)鈀(II);甲磺酸(2-二環(huán)己基膦基-2,6-二異丙氧基-1,1-聯(lián)苯基)(2-氨基-1,1-聯(lián)苯-2-基)鈀(II);泰諾福韋標(biāo)準(zhǔn)品;泰諾福韋一水物;泰諾福韋酯;替諾福韋-D6;泰諾福韋 PMPA;泰諾福韋, 替諾福韋;泰諾福偉;替諾福韋酯;(R)-[[2-(6-氨基-9H-嘌呤-9-基)-1-甲基乙氧基]甲基]膦酸 水合物;提諾福韋;替諾福韋API;泰諾福韋游離堿;泰諾福韋酯中間體3;泰諾福韋 1KG |
| 英文名稱： |
Tenofovir |
| 英文別名： |
Tenofovir;1-(6-aminopurin-9-yl)propan-2-yloxymethylphosphonic acid;D,L-TENOFOVIR;(R)-9-(2-PHOSPHONYLMETHOXYPROPYL)-ADENINE;(R)-9-(2-Phosphonomethoxypropyl)Adenine;Tenofovir(ForResearchOnly);(R)-PMPA;[[(1R)-2(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic Acid;Tenofovir (PMPA);Tenofovir Hydrate;(R)-(((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonic acid;(R)-(1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid;9-Pmpa;Apropovir;GS 1278;GS-1278;PMPA;TDF;Tenefovir;Viread;(R)-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic Acid Hydrate;GS 1275;Tenofovi;Aids021800;9-[(R)-2-(Phosphonomethoxy)propyl]adenine;PMPA gel;(R)-9-[2-(Phosphonomethoxy)propyl]adenine;W4HFE001U5;({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid;Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl;(R)-9-(2-Phosphonomethoxypropyl)adenine;1-(6-Aminopurin-9-yl)propan-2-yloxymethylphosphonic acid;TENOFOVIR;A808613;tenofovir (anhydrous);GTPL10948;PMP-A;((((2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonic acid;tenofovirum;BRD-K15891719-001-02-8;SR-01000883934;(R)-9-(Phosphonomethoxypropyl)adenine Hydrate;Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, (R)-;CHEMBL483;HMS3264H05;MFCD00943794;Z1546616194;UNII-W4HFE001U5;DTXSID9040132;EC 604-571-2;9-(2-Phosphonylmethoxypropyl)adenine;(R)-9-[2-(phosphonomethoxy) propyl] adenine;9-((R)-2-PHOSPHONOMETHOXY-PROPYL)ADENINE MONOHYDRATE;[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID;AB01274787_03;AKOS015894941;Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA);Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, monohydrate, (R)-;9-PMPA (tenofovir);CHEBI:63716;D,L-Tenofovir;AC-760;anhydrous tenofovir;DB14126;NCGC00167535-16;TENOFOVIR [INN];Q-201787;NS00000521;HY-13910;CCG-267345;{[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonic acid;[[(1R)-2(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic Acid;;AM20090678;BT164455;Tenofovir anhydrous;Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-;[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid;(((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic acid;(R)-((2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic acid monohydrate;AKOS015856701;(R)-(((1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONIC ACID;DTXCID7020132;(R)-9-(2-Phosphonomethoxypropyl)adenine Hydrate;(R)-9-(2-Phosphonoylmethoxypropyl)adenine;TENOFOVIR [MI];C9H14N5O4P;Tenofovir gel (GS-1278);[[(1R)-2(6-Amino-9H-Purin-9-Yl)-1-Methylethoxy]Methyl]Phosphonic Acid;BDBM50450813;CS-1609;J05AF07;(((R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic acid, monohydrate;SR-01000883934-1;Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methy... |
| 品牌： |
PERFEMIKER |
| CAS號： |
147127-20-6 |
| 分子式： |
C9H14N5O4P |
| 分子量： |
287.21 |
| 純度： |
98% |
| 詳細(xì)描述： |
博飛美科的泰諾福韋,98%為醫(yī)藥中間體,產(chǎn)品穩(wěn)定,定制速度快,極大地方便了廣大科研客戶的使用需求。產(chǎn)品包裝為5g。查詢關(guān)鍵詞:醫(yī)藥中間體，147127-20-6，泰諾福韋,98%，Tenofovir，博飛美科，Perfemiker，上海，廠家現(xiàn)貨。 |
滬公網(wǎng)安備31011402010658號 
